Aurora Concussion Therapy Systems, Inc.
Helping the brain heal faster from concussions.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Saint Paul, MN, USA
- Currency USD
- Founded October 2018
- Employees 2
- Incorporation Type C-corp
- Website aurora-cts.com
Company Summary
Aurora Concussion Therapy Systems is an early stage medical device company focused on commercialization of a non-invasive concussion therapy. In 2019, an estimated 2.3M people in the U.S. will be diagnosed with a concussion in emergency rooms. The healthcare cost is estimated to be over $5.5B. While significant advances have been made in concussion diagnosis, concussion therapy has not kept pace. Our therapy represents an estimated $2.3B market.
Team
-
CEO35 years of urology, cardiovascular, and orthopedic development and commercialization experience at multiple start-up and multi-national companies.
Executive leadership, CEO/GM, Marketing, and Business Development experience at AMS, Schneider (PFZ), BSX, IntraTherapeutics, ZBH, SRDX, CSI, Preventice, Intact Vascular, SPNC, and Biocoat.
Board experience at Biocoat, NeuroVasx, and Computational Life
Fund-raising and liquidity experience. -
CTOPh.D. in chemical engineering from U.C. Berkeley and a BS degree from M.I.T.
17 years of medical device research and development leadership experience.
10 product launches at AMS, BSX, Coloplast, and 3M.
31 patents granted and applied for. -
Geoff DanielDirector, Quality Engineering16 years of medical device reasearch and development experience at Angeon, Coloplast, and Boston Scientific.
6 years of electronics design and fixture fabrication experience to support the development of our therapy.
29 patents granted and applied for
Advisors
-
Kathy TuneUnconfirmed
Dr. Jeffrey KutcherUnconfirmed -
Ben UtechtUnconfirmed
Previous Investors
-
Doug DevensUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.